This inventor holds 1 USPTO granted patent. Top assignees: Mycosynthetix, Inc., The Ohio State University, University of Illinois. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 1 
1 out of 1,584 
1 out of 2,437 
Years Active: 2025
Title: Chiraz Soumia Amrine: Innovator in Cancer Treatment
Introduction
Chiraz Soumia Amrine is a notable inventor based in Greensboro, NC (US). He has made significant contributions to the field of cancer treatment through his innovative research and development of new compounds.
Latest Patents
Amrine holds a patent for "Semi-synthetic analogues of epipolythiodioxopiperazine alkaloids." This patent discloses compounds, compositions, and methods for inhibiting a histone methyltransferase. The compounds are verticillin derivatives that exhibit anti-proliferative activity against cancer cells. These compounds, compositions, and methods can be utilized to treat subjects with cancer. He has 1 patent to his name.
Career Highlights
Throughout his career, Amrine has worked with esteemed organizations such as the Ohio State Innovation Foundation and the University of North Carolina at Greensboro. His work has focused on developing innovative solutions to combat cancer, showcasing his dedication to improving patient outcomes.
Collaborations
One of his notable collaborators is Andrew Huntsman. Their partnership has contributed to advancing research in the field of cancer treatment.
Conclusion
Chiraz Soumia Amrine is a dedicated inventor whose work in cancer treatment has the potential to make a significant impact on the medical field. His innovative approaches and collaborations highlight the importance of research in developing effective therapies for cancer patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile